LIFECORE BIOMEDICAL, INC. Related Party Transaction, Purchases from Related Party
LIFECORE BIOMEDICAL, INC. (LFCR) reported Related Party Transaction, Purchases from Related Party of $570.00 thousand for the 3-month period ending 2014-02-23, per its 10-Q filed 2014-03-28.
Discontinued › Notes › Related Party Transactions
us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty · last filed 2014-03-28
- LIFECORE BIOMEDICAL, INC. related party transaction, purchases from related party for the quarter ending 2014-02-23 was $570.00K, a 38.91% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. related party transaction, purchases from related party for the quarter ending 2013-11-24 was $759.00K, a 55.35% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. related party transaction, purchases from related party for the quarter ending 2013-08-25 was $1.90M, a 13.64% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. related party transaction, purchases from related party for the quarter ending 2013-02-24 was $933.00K, a 0.74% decline year-over-year.
| Period end | Related Party Transaction, Purchases from Related Party 3 month | Related Party Transaction, Purchases from Related Party 6 month | Related Party Transaction, Purchases from Related Party 9 month |
|---|---|---|---|
| 2014-02-23 | $570.00K 10-Q · filed 2014-03-28 | $1.33M derived: sum of 2 quarters · filed 2014-03-28 | $3.20M 10-Q · filed 2014-03-28 |
| 2013-11-24 | $759.00K 10-Q · filed 2014-01-03 | $2.70M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $1.90M 10-Q · filed 2013-09-26 | ||
| 2013-02-24 | $933.00K 10-Q · filed 2014-03-28 | $2.63M derived: sum of 2 quarters · filed 2014-03-28 | $4.80M 10-Q · filed 2014-03-28 |
| 2012-11-25 | $1.70M 10-Q · filed 2014-01-03 | $3.80M 10-Q · filed 2014-01-03 | |
| 2012-08-26 | $2.20M 10-Q · filed 2013-09-26 | ||
| 2012-02-26 | $940.00K 10-Q · filed 2013-04-04 | $3.80M 10-Q · filed 2013-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |